A detailed history of Cutter Capital Management, LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cutter Capital Management, LP holds 359,025 shares of GILD stock, worth $32.4 Million. This represents 8.88% of its overall portfolio holdings.

Number of Shares
359,025
Previous 292,959 22.55%
Holding current value
$32.4 Million
Previous $20.1 Billion 49.76%
% of portfolio
8.88%
Previous 6.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$66.59 - $83.99 $4.4 Million - $5.55 Million
66,066 Added 22.55%
359,025 $30.1 Billion
Q2 2024

Aug 14, 2024

BUY
$63.15 - $72.88 $1.74 Million - $2.01 Million
27,523 Added 10.37%
292,959 $20.1 Billion
Q1 2024

May 15, 2024

BUY
$71.58 - $87.29 $19 Million - $23.2 Million
265,436 New
265,436 $19.4 Billion

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Cutter Capital Management, LP Portfolio

Follow Cutter Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutter Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutter Capital Management, LP with notifications on news.